Hancock Jaffe Laboratories IncのEV/EBIT
Hancock Jaffe Laboratories IncのEV/EBITは何ですか。
Hancock Jaffe Laboratories IncのEV/EBITはN/Aです。
EV/EBITの定義は何ですか。
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
NASDAQのセクタHealth CareにおけるEV/EBITの企業と比べるHancock Jaffe Laboratories Inc
Hancock Jaffe Laboratories Incは何をしますか。
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Hancock Jaffe Laboratories Incと類似のev/ebit
- ChesapeakeのEV/EBITはN/Aです。
- DynatronicsのEV/EBITはN/Aです。
- North Peak ResourcesのEV/EBITはN/Aです。
- Angiodynamic IncのEV/EBITはN/Aです。
- TGB Banquets and HotelsのEV/EBITはN/Aです。
- Enviroleach TechnologiesのEV/EBITはN/Aです。
- Hancock Jaffe Laboratories IncのEV/EBITはN/Aです。
- Atyr Pharma IncのEV/EBITはN/Aです。
- SCWorx CorpのEV/EBITはN/Aです。
- Solid Biosciences IncのEV/EBITはN/Aです。
- Meteorite CapitalのEV/EBITはN/Aです。
- Simran FarmsのEV/EBITはN/Aです。
- ComscoreのEV/EBITはN/Aです。